DEFLOPAM 6 (Deflazacort (6mg))

Deflomac 6 Tablet is classified as a steroid medication and is indicated for the management of various inflammatory and autoimmune disorders. Its primary mechanism involves suppressing the release of chemicals that contribute to inflammation or by modifying the function of the immune system. The tablet can be administered either on an empty stomach or following meals; however, adherence to a consistent dosing schedule is essential to optimize its therapeutic effects. Patients are advised to continue taking this medication as prescribed by their healthcare provider until they receive specific guidance regarding discontinuation. Potential adverse effects associated with Deflomac 6 may include increased appetite, weight gain, a frequent need to urinate, Cushing syndrome, cough, upper respiratory infections, abnormal hair growth, obesity, and nasopharyngitis. It is crucial to communicate with your healthcare provider if any of these side effects become troublesome. Additionally, Deflomac 6 may impair the body’s ability to combat infections, so reporting symptoms indicative of an infection, such as fever or sore throat, to your doctor is advisable. Before initiating treatment, patients should disclose all other medications they are currently using. Consultation with a healthcare professional is recommended for pregnant or nursing women prior to starting this medication. Use this medicine only under medical supervision. Follow the dose and schedule exactly as advised. Do not stop abruptly without guidance. Keep a record of any unusual symptoms and share them with your clinician. Combine therapy with appropriate lifestyle measures and routine monitoring as recommended.